Trophic Communications GmbH

https://www.trophic.eu

	Start	2017-10-24 established
	Predecessor	MacDougall Biomedical Communications Inc. (MBI), European Office
	Industry	public relations / investor relations / marcom (services)
	Person	Tostmann, Holger (Trophic Communications GmbH 201710– Managing Director)
	Person 2	Schweitzer, Gretchen (Trophic Comunications 201801 before MacDougall European Office)

	Region	München (Munich)
	Country	Germany
	Street	16 Kidlerstr.
	City	81371 München
	Tel	+49-89-238877-30
		Address record changed: 2024-01-05

Basic data	Employees	n. a.


		Record changed: 2024-07-30

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Trophic Communications GmbH

[1] Immatics N.V.. (5/1/23). "Press Release: Immatics Announces First Bristol Myers Squibb Opt-in of TCR-T Candidate from Ongoing Multi-target Strategic Collaboration". Tübingen & Houston, TX....
[2] Immatics N.V.. (10/10/22). "Press Release: Immatics Reports Interim Clinical Data Update on ACTengine IMA203 TCR-T Monotherapy Targeting PRAME". Houston, TX & Tübingen....
[3] Catalym GmbH. (9/26/22). "Press Release: Catalym Receives FDA IND Clearance to Expand Development of Visugromab in Advanced Cancer Patients into the U.S.". Munich....
[4] InteRNA Technologies B.V.. (2/16/21). "Press Release: InteRNA Technologies Announces Dosing of First Patient in First-in-Human Trial of microRNA Drug Candidate INT-1B3 in Patients with Advanced Solid Tumors". Utrecht....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]